CBS 2019
CBSMD教育中心
中 文

动脉粥样硬化性心血管疾病预防

Abstract

Recommended Article

Systemic microvascular dysfunction in microvascular and vasospastic angina Metabolic Interactions and Differences between Coronary Heart Disease and Diabetes Mellitus: A Pilot Study on Biomarker Determination and Pathogenesis ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography) developed in collaboration with the Society of Atherosclerosis Imaging and Prevention and the Society of Cardiovascular Computed Tomography 2019 Guidelines on Diabetes, Pre-Diabetes and Cardiovascular Diseases developed in collaboration with the EASD ESC Clinical Practice Guidelines Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy From Subclinical Atherosclerosis to Plaque Progression and Acute Coronary Events Coronary calcification in the diagnosis of coronary artery disease Association of Circulating Monocyte Chemoattractant Protein-1 Levels With Cardiovascular Mortality: A Meta-analysis of Population-Based Studies

Guideline31 August 2019

JOURNAL:Eur Heart J. Article Link

2019 Guidelines on Diabetes, Pre-Diabetes and Cardiovascular Diseases developed in collaboration with the EASD ESC Clinical Practice Guidelines

F Cosentino, PJ Grant, ESC Scientific Document Group et al. Keywords: guidelines; diabetes mellitus; impaired glucose tolerance; cardiovascular diseases; epidemiology; risk factors; prevention; cardiovascular risk assessment; patient management; pharmacological treatment; revascularization; patient-centred care

FULL TEXT PDF